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BY 
1. Chair’s Introduction and Apologies 
The Chair welcomed everyone to today’s meeting and submitted apologies on 
behalf of those unable to attend. The Chair also advised that Joanne Boyle, Head 
of Business Engagement at DHI will attend the meeting this morning to give a 
presentation to the Board on the Atrial Fibrillation project. 
 
 
2. Declarations of Interest 
None to note. 
 
 
3. 
 
 
Minutes of Previous Meeting 
The minutes of 22nd November were reviewed and agreed as an accurate 
record. The Chair asked colleagues to note the following: - 
 
• SS confirmed amendment was made to the previous minute as per MW 
clarification. 
• JJ apologised for the late circulation of the findings from the Board 
Effectiveness review and advised that he would like to spend some time 
at the May Board meeting to discuss Board Governance/structure 
further. 
• Item 5. Decision Support – MM advised that she is currently having 
discussions with UoS Business School Colleagues. MM will update 
colleagues on progress at the May meeting.  
• Item 7. JH advised that extension to contracts have now been agreed 
and are complete. 
• Item 9. Corporate Risk Log – JJ advised that this item will be deferred to 
the May meeting, which will be extended to facilitate a Corporate Risk 
Workshop for Board colleagues. This will be facilitated by a UoS Risk 
and Resilience Manager. 
 
 
 
 
 
 
 
 
 
 
 
 
MM 
4. Chairman’s Update (verbal) 
JJ updated colleagues on recent meetings that he has attended with two 
companies, who are interested in the work that DHI are progressing in the DSE 
around patient data. JJ has introduced both companies to the DHI CEO for further 
discussions. JJ advised that one company is privately owned and the other has 
recently floated on the public markets, with both having capital available to invest 
in the data driven health and care technology. Please see attached link below for 
further information on one of the companies discussed. JJ suggested that a 
meeting with DHI and both enterprise agencies be arranged to discuss their 
potential involvement with these companies. GC agreed to action this. 
(https://www.sensynehealth.com/) 
 
JJ also advised on the life science industrial strategy and the role of Health Data 
Research UK (HDR UK); of which Board colleague Andrew Morris is CEO. LMcK 
advised that UoS, along with several other Universities have collaboration 
agreements with HDR UK and it may be worth investigating the relationship with 
the host university further. 
 
JJ advised that there is currently a risk around the DSE with a potential move 
from the 7th floor of the TIC building. JJ is currently in discussions with the 
Principal on this issue.  
 
 
 
 
 
 
 
 
JJ 
 
GC 
  
JJ suggested using some time during the May Board meeting to discuss the 
potential appointment of new members to the Board. DL suggested contacting 
IBioIC, who have recently had a very successful recruitment process with new 
Board members appointed. GC advised that he has already been in touch with 
IBioIC CEO. 
 
5. CEO Update 
GC confirmed that following the submission of the DHI Business Case to SFC in 
October, SFC had some further questions to be addressed, which DHI responded 
to in December. SFC are currently having a gateway review and DHI is awaiting 
a decision on the final grant award. HR would like to note her thanks to the DHI 
team for their hard work on the Business Case presented and subsequent 
updates on behalf of SFC. HR advised that there will be a meeting on the 15 th 
February re the Gateway Review. HR stated that as yet, there has been no update 
on FEC but hopes to have this information soon. She will contact the DHI when 
she has been given the final decision. 
  
GC advised that there may be a potential delay on the final grant award decision 
by SFC, extending from March to April. Should this prove to be the case, further 
discussions and requests to extend contracts will need to be addressed. JJ 
advised that he has concerns over recruitment and retention of staff at DHI, with 
4 members of staff leaving DHI recently. JJ agreed to draft a joint letter with the 
Principal of UoS to SFC around his concerns on staffing and potential risk to 
future recruitment, exacerbated by the delay of the funding award.  
 
GC also advised that the early indicative figure by SFC on the final grant award 
is lower than that of option 4, agreed by the Board. The current figure projected 
is closer to option 2, which covers existing core costs. GC advised that DHI will 
not be looking to reduce its ambition and discussions are under way re other 
funding sources. GC advised there will be no change to the proposed staffing 
structure in the Business Case, but this may now require a phased 
implementation. GC then described the organisational structure highlighting the 
posts which are covered by core funding and others that will require additional 
funding. GC advised that 2 members of staff have already left, with 2 further 
senior members leaving at the end of the month (a senior member of the Design 
team and DHI’s Business Development Manager). The DHI Executive team have 
agreed to pause on recruitment for these two posts until the final funding decision 
is reached. Discussion ensued, and it was agreed that recruitment processes 
should be prepared for both posts, to be actioned  once the final award notice is 
received. 
 
GC asked colleagues to note that DHI has been shortlisted for a series of awards 
at the Digital Health and Care Awards event on 20th February. DHI has a table 
and a representative from SFC has been invited. Should they be unable to attend, 
the invitation will be extended to a member of the Board. GR will send out further 
details of the event to all Board members. 
 
GC also advised that Digi-Inventors 3 was launched last week and would like to 
thank GR for all the hard work involved in preparation of the launch and on 
securing sponsorship from Microsoft, Orcha and Sitekit. GR advised that this year 
will be a more cost-effective event, as DHI own most of the assets, ensuring that 
the majority of the work involved will be predominantly inhouse.  
GC asked colleagues to note that DHI has taken a leadership role in developing 
Scotland’s Healthy Ageing Cluster. To date, 127 organisations have signed up to 
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join, bringing together skills and expertise from across industry, the public sector, 
academia and the third sector. 
 
6. Atrial Fibrillation (AF) Presentation – Joanne Boyle 
JB attended today’s meeting to give an update and overview of the AF Project  
from its inception to date. JB advised that this project is a collaborative partnership 
with UoS, Napier and GSA. JB advised that it is estimated there are around 125 
thousand people in Scotland with undetected AF, which can lead to more serious 
complications and stroke. Currently AF uses up to 5% of the NHS budget. JB then 
went on to describe current monitoring processes, the cost of expensive devices 
used at the moment, the significant strain on resources compounded by a 
shortage of cardiac physiologists. JB then went on to advise that new devices 
have recently been procured and will be deployed in the coming months to around 
60 patients within NHS Lanarkshire. A PR exercise is currently planned around 
staff training on 14th February. JB circulated the embargoed press release to 
colleagues for information. GR will also send a digital copy to SFC for 
dissemination when appropriate. SS will disseminate JB presentation following 
today’s meeting. 
 
Professor Iain Stewart, Associate Principal and Executive Dean from faculty of 
science joined today’s meeting.  
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6. Finance and Governance Update (for approval) 
MM asked colleagues to note the financial performance at month 21 of DHI Phase 
1B, MM advised that Phase 1B has been extended by SFC to the end of June. 
MM asked colleagues to review the financial report and note appendix 2 (Phase 
1b extension – core grant funding). These are the projections until the end of 
June. MM also advised that DHI will be seeking a further additional extension to 
the additional funding application, in order for staff to avoid termination of contract 
notices. The CEO will contact SFC colleagues next week. Board colleagues 
approved the DHI Phase 1b budget extension.   
 
 
 
8. SFC Retrospective MEF Approval (for retrospective noting) 
JH asked Board colleagues to retrospectively note the MEF quarterly report 
(quarter 1), submitted to SFC in November. Noted by Board. 
 
 
9. Performance and Planning Update (for noting) 
JH asked colleagues to note progress to the DHI Phase 1a and 1b projects. JH 
advised that 6 projects will be complete before June 2019. SCOTCAP and AF will 
run beyond June due to delays in the procurement process. JH asked colleagues 
to note the following: - 
 
• SCOTCAP – Work is currently progressing with the procurement process 
underway. It is hoped that a service provider will be appointed by the end 
of April 2019.  
• AF – as previously updated by JB’s presentation 
• Diabetes – Future state mapping should be in place for the next Board 
meeting, with potential opportunities arising for DHI Phase 2. It was 
agreed that this will be added as an agenda item to the May Board 
meeting to allow time for a fuller discussion to take place. 
• SAC – workshops are well underway, and reports have been produced 
and widely disseminated on those areas completed to date. JH advised 
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that the national sponsor has moved post, but the project has not lost any 
momentum with NHS Tayside and NHS GG&C interested in the process. 
• Next Generation Asthma – JH advised that future mapping work 
continues and scoping of a potential DHI 2 project. 
• DSE – JH advised colleagues that there is a potential risk surrounding the 
DSE environment, with UoS considering a move of the facility from its 
current location on the 7th Floor of the TIC building. JH will be attending a 
meeting next week with UoS and Estates department to discuss further.  
• Macmillan – Additional funding of £41k has been given by Macmillan to 
extend the existing project with discussions of a potential project in phase 
2 also taking place. 
• Decision Support – Right Decision platform has been developed with 
national roll out across all boards for diabetes decision support.  
• ValMed (Janssen) – JH advised that this additional project had contracts 
concluded in December. This will be a short project and JH will advise at 
the next meeting of the Board in May. A meeting has also taken place to 
discuss deliverables and time frames. 
• NEW.CHANCE – JH advised that this is an early stage project with 
meetings taking place to discuss project plan and agree deliverables. 
 
10. DHI Phase 2 Prioritisation Process Presentation – Janette Hughes 
JH presented to colleagues DHI prioritising process. JH advised that the focus 
will be to achieve and maintain balance and spread across the portfolio. JH then 
went on to discuss the need to balance themes and maturity/readiness levels. 
These will be decided by SMT, in consultation with the Strategic Advisory Group. 
JH presented the four-stage process with relevant stage gates for 
decision/approval. It was agreed by the Board that this seems an acceptable 
process at the highest level and SMT should consider in more detail the score 
card and criteria that sits behind this process. DL also suggested having an 
additional line above 9 re adoption and scale. It was agreed this would be brought 
back to the Board in May.  
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11. Corporate Risk Log (for approval) 
JJ advised that all items should have been covered in today’s agenda. The 
corporate risk log was therefore approved. 
 
 
12. AOB 
• Board members and deputes - DL suggested that in order to ensure the 
Board meetings are quorate, that members should send a depute to 
represent them should they be unable to attend. UoE has had no 
representative attend DHI Board meetings to date. JJ agreed to discuss 
this further with AM, and the need for a UoE depute at the meetings. JJ 
advised that he will send out an email to all Board members re future 
attendees. As previously discussed earlier through the course of today’s 
agenda, general Board governance will be discussed at the next meeting 
in May. 
 
 
 
 
 
JJ 
 
JJ 
 
12. Date and Time of the Next Meeting 
The next scheduled Board meeting will take place on Wednesday 15th May 2019 
@10am until 2pm in the ground floor Boardroom of the Inovo Building. The 
meeting will be extended by approximately 1 hour to accommodate a planned 
Corporate Risk Workshop for Board Colleagues. This will be facilitated by a Risk 
and Resilience Manager from UoS. 
 
 
 
 
